JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yoshiki Sawa
Masahiro Sakurai
Goro Matsumiya
Hikaru Matsuda
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamauchi, T.
Right arrow Articles by Matsuda, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamauchi, T.
Right arrow Articles by Matsuda, H.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Cerebral protection
Right arrow Great vessels

J Thorac Cardiovasc Surg 2006;131:644-650
© 2006 The American Association for Thoracic Surgery


Cardiopulmonary Support and Physiology

ONO-5046 attenuation of delayed motor neuron death and effect on the induction of brain-derived neurotrophic factor, phosphorylated extracellular signal–regulated kinase, and caspase3 after spinal cord ischemia in rabbits

Takashi Yamauchi, MD a , Yoshiki Sawa, MD, PhD a , * , Masahiro Sakurai, MD, PhD b , Takano Hiroshi, MD, PhD b , Goro Matsumiya, MD, PhD b , Koji Abe, MD, PhD c , Hikaru Matsuda, MD, PhD a

a Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
b Department of Cardiovascular Surgery, National Hospital Organization Sendai Medical Center, Sendai, Japan
c Department of Neurology, Okayama University Graduate School of Medicine, Okayama, Japan

Received for publication December 26, 2004; revisions received April 20, 2005; accepted for publication June 20, 2005.

* Address for reprints: Yoshiki Sawa, MD, PhD, Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. (Email: sawa{at}surg1.med.osaka-u.ac.jp).

OBJECTIVE: The mechanism of spinal cord injury is believed to be related to the vulnerability of spinal motor neuron cells to ischemia. The aim of this study was to investigate whether ONO-5046, a specific inhibitor of neutrophil elastase that can attenuate tissue or organ injury in various pathologic conditions, could protect against ischemic spinal cord damage.

METHODS: After induction of spinal ischemia, ONO-5046 or vehicle was injected intravenously. Cell damage was analyzed by counting the number of motor neurons. To investigate the mechanism by which ONO-5046 prevents ischemic spinal cord damage, we observed the immunoreactivity of CPP32 (caspase3), brain-derived neurotrophic factor, and phosphorylated extracellular signal–regulated kinase.

RESULTS: ONO-5046 eased the functional deficits and increased the number of motor neurons after ischemia. The induction of caspase3 was significantly reduced by ONO-5046 treatment. Furthermore, the expressions of brain-derived neurotrophic factor and phosphorylated extracellular signal–regulated kinase were prolonged.

CONCLUSION: ONO-5046 may protect motor neurons from ischemic injury by reducing caspase3 and prolonging the expressions of brain-derived neurotrophic factor and phosphorylated extracellular signal–regulated kinase. ONO-5046 may be a strong candidate for use as a therapeutic agent in the treatment of ischemic spinal cord injury.



Abbreviations and Acronyms BDNF = brain-derived neurotrophic factor; ERK = extracellular signal–regulated kinase; MEK = mitogen-activated protein kinase/ERK kinase; p-ERK = phosphorylated extracellular signal–regulated kinase





This article has been cited by other articles:


Home page
Interact CardioVasc Thorac SurgHome page
S. Iwamoto, A. Higashi, T. Ueno, M. Goto, Y. Iguro, and R. Sakata
Protective effect of sivelestat sodium hydrate (ONO-5046) on ischemic spinal cord injury
Interact CardioVasc Thorac Surg, June 1, 2009; 8(6): 606 - 609.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The American Association for Thoracic Surgery.